{"id":71374,"date":"2017-11-07T20:05:39","date_gmt":"2017-11-07T20:05:39","guid":{"rendered":"http:\/\/humanitasnet-new.local\/malattie\/karcinom-hurtleo-vih-celija\/"},"modified":"2025-01-13T02:57:12","modified_gmt":"2025-01-13T02:57:12","slug":"karcinom-hurtleo-vih-celija","status":"publish","type":"disease","link":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","title":{"rendered":"Karcinom Hurtleo-vih \u0107elija"},"content":{"rendered":"

Karcinom Hurtle-ovih \u0107elija, poznat kao karcinom oksifilnih \u0107elija, predstavlja redak tip karcinoma koji se javlja u \u0161titastoj \u017elezdi. <\/span><\/p>\n

\u0160titasta \u017elezda predstavlja organ oblika leptira sa bazom lokalizovanom u regiji vrata. Funkcija \u0161titaste \u017elezde jeste sekrecija hormona koji su od vitalnog zna\u010daja za metaboli\u010dke procese\u00a0 u organizmu.<\/span><\/p>\n

Karcinom Hurtle-ovih \u0107elija mo\u017ee biti znatno agresivnijeg toka u odnosu na ostale karcinome tiroidee. Naj\u010de\u0161\u0107i terapeutski pristup podrazumeva operativni pristup u cilju uklanjanja celokupne \u0161titaste \u017elezde.<\/span><\/p>\n

 <\/p>\n

Simptomi<\/span><\/h2>\n

Simptomi karcinoma Hurtle-ovih \u0107elija uklju\u010duju:<\/span><\/p>\n

Brzo-rastu\u0107i nodus vratne regije (ispod Adamove jabu\u010dice)<\/span><\/p>\n

Bol u predelu vrata ili grla<\/span><\/p>\n

Gubitak daha<\/span><\/p>\n

Promuklost ili druge glasovne promene<\/span><\/p>\n

Te\u0161ko\u0107e pri gutanju<\/span><\/p>\n

Navedeni simptomi nisu apsolutno indikativni za karcinom Hurtleo-vih \u0107elija. Mogu biti indikativni i za inflamatorna oboljenja \u0161titaste \u017elezde ili nekancerozna uve\u0107anja \u0161titaste \u017elezde (nodusi).<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Uzroci<\/span><\/h2>\n

Ta\u010dan etiopatogenetski mehanizam nastanka karcinoma Hurtleovih \u0107elija jo\u0161 uvek je nepoznat.<\/span><\/p>\n

Karcinom nastaje prilikom gre\u0161aka u sopstvenoj DNA \u010delija. Naru\u0161ena struktura DNA mo\u017ee izazvati abnormalno funkcionalne gene \u0161to rezultuje u hiperprodukciji\u00a0 i poja\u010danom\u00a0 rastu abnormalnih \u0107elija sa formiranjem tumorske mase odnosno nakupina karcinomskih \u0107elija.<\/span><\/p>\n

 <\/p>\n

Fakori rizika<\/span><\/h2>\n

Faktori rizika za nastanak karcinoma Hurtle-ovih \u0107elija mogu biti:<\/span><\/p>\n

\u017denski pol<\/span><\/p>\n

Starije \u017eivotno doba<\/span><\/p>\n

Prethodna istorija terapeutskog zra\u010denja regije glave i vrata.<\/span><\/p>\n

 <\/p>\n

Komplikacije<\/span><\/h2>\n

Potencijalne komplikacije karcinoma Hurtle-ovih \u0107elija mogu uklju\u010divati: <\/span><\/p>\n

Pote\u0161ko\u0107e prilikom gutanja i disanja usled kompresije ezofagusa i du\u0161nika (traheje)<\/span><\/p>\n

\u0160irenje tumora u druge organe ili tkiva (metastaze).<\/span><\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-71374","disease","type-disease","status-publish","hentry"],"yoast_head":"\nKarcinom Hurtleo-vih \u0107elija - Humanitas.net<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"sr_RS\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Karcinom Hurtleo-vih \u0107elija - Humanitas.net\" \/>\n<meta property=\"og:description\" content=\"Karcinom Hurtle-ovih \u0107elija, poznat kao karcinom oksifilnih \u0107elija, predstavlja redak tip karcinoma koji se javlja u \u0161titastoj \u017elezdi. \u0160titasta \u017elezda predstavlja organ oblika leptira sa bazom lokalizovanom u regiji vrata. Funkcija \u0161titaste \u017elezde jeste sekrecija hormona koji su od vitalnog zna\u010daja za metaboli\u010dke procese\u00a0 u organizmu. Karcinom Hurtle-ovih \u0107elija mo\u017ee biti znatno agresivnijeg toka u […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\" \/>\n<meta property=\"og:site_name\" content=\"Humanitas.net\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HumanitasInternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T02:57:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@humanitasmilano\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\",\"name\":\"Karcinom Hurtleo-vih \u0107elija - Humanitas.net\",\"isPartOf\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\"},\"datePublished\":\"2017-11-07T20:05:39+00:00\",\"dateModified\":\"2025-01-13T02:57:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb\"},\"inLanguage\":\"sr-RS\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Malattie\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Karcinom Hurtleo-vih \u0107elija\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"name\":\"Humanitas.net\",\"description\":\"Humanitas Hospital\",\"publisher\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sr-RS\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\",\"name\":\"Humanitas\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sr-RS\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"contentUrl\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"width\":1,\"height\":1,\"caption\":\"Humanitas\"},\"image\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/HumanitasInternational\/\",\"https:\/\/x.com\/humanitasmilano\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Karcinom Hurtleo-vih \u0107elija - Humanitas.net","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"sr_RS","og_type":"article","og_title":"Karcinom Hurtleo-vih \u0107elija - Humanitas.net","og_description":"Karcinom Hurtle-ovih \u0107elija, poznat kao karcinom oksifilnih \u0107elija, predstavlja redak tip karcinoma koji se javlja u \u0161titastoj \u017elezdi. \u0160titasta \u017elezda predstavlja organ oblika leptira sa bazom lokalizovanom u regiji vrata. Funkcija \u0161titaste \u017elezde jeste sekrecija hormona koji su od vitalnog zna\u010daja za metaboli\u010dke procese\u00a0 u organizmu. Karcinom Hurtle-ovih \u0107elija mo\u017ee biti znatno agresivnijeg toka u […]","og_url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","og_site_name":"Humanitas.net","article_publisher":"https:\/\/www.facebook.com\/HumanitasInternational\/","article_modified_time":"2025-01-13T02:57:12+00:00","twitter_card":"summary_large_image","twitter_site":"@humanitasmilano","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/","name":"Karcinom Hurtleo-vih \u0107elija - Humanitas.net","isPartOf":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website"},"datePublished":"2017-11-07T20:05:39+00:00","dateModified":"2025-01-13T02:57:12+00:00","breadcrumb":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb"},"inLanguage":"sr-RS","potentialAction":[{"@type":"ReadAction","target":["https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/karcinom-hurtleo-vih-celija\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/"},{"@type":"ListItem","position":2,"name":"Malattie","item":"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/"},{"@type":"ListItem","position":3,"name":"Karcinom Hurtleo-vih \u0107elija"}]},{"@type":"WebSite","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website","url":"https:\/\/humanitas-net.humweb.webiz.team\/","name":"Humanitas.net","description":"Humanitas Hospital","publisher":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sr-RS"},{"@type":"Organization","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization","name":"Humanitas","url":"https:\/\/humanitas-net.humweb.webiz.team\/","logo":{"@type":"ImageObject","inLanguage":"sr-RS","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","contentUrl":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","width":1,"height":1,"caption":"Humanitas"},"image":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HumanitasInternational\/","https:\/\/x.com\/humanitasmilano"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/disease\/71374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/disease"}],"about":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/types\/disease"}],"wp:attachment":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/media?parent=71374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}